John Kenneth Jenkins
Director, Corbus Pharmaceuticals.
Companies
- Corbus PharmaceuticalsBoard member Jun 6, 2018 to now1
- Provention Bio, Inc.Board member Aug 11, 2020 to Apr 27, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Corbus Pharmaceuticals CRBP3,833 shares3$16.9K at $4.40Jun 10, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 10, 2026Sold 4,800 shares at $7.91 of Corbus Pharmaceuticals3
- May 19, 2026Granted 3,800 shares of Corbus Pharmaceuticals4
- May 30, 2025Granted 4,800 shares of Corbus Pharmaceuticals5
- May 30, 2025Sold 2,783 shares at $7.35 of Corbus Pharmaceuticals5
- May 30, 2024Granted 2,783 shares of Corbus Pharmaceuticals6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCorbus Pharmaceuticals, Board member
- 2SEC EDGARProvention Bio, Inc., Board member
- 3
- 4SEC EDGARForm 4 filed May 21, 2026
- 5SEC EDGARForm 4 filed Jun 2, 2025
- 6SEC EDGARForm 4 filed Jun 3, 2024